ATE444072T1 - Prävention von epithelzellkarzinom - Google Patents

Prävention von epithelzellkarzinom

Info

Publication number
ATE444072T1
ATE444072T1 AT02759763T AT02759763T ATE444072T1 AT E444072 T1 ATE444072 T1 AT E444072T1 AT 02759763 T AT02759763 T AT 02759763T AT 02759763 T AT02759763 T AT 02759763T AT E444072 T1 ATE444072 T1 AT E444072T1
Authority
AT
Austria
Prior art keywords
cancer
prevention
prostate
bladder
lung
Prior art date
Application number
AT02759763T
Other languages
English (en)
Inventor
Hans Raskov
Original Assignee
Colotech As
Raskov Hans Henrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/825,891 external-priority patent/US6703380B2/en
Application filed by Colotech As, Raskov Hans Henrik filed Critical Colotech As
Application granted granted Critical
Publication of ATE444072T1 publication Critical patent/ATE444072T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT02759763T 2001-04-05 2002-04-05 Prävention von epithelzellkarzinom ATE444072T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/825,891 US6703380B2 (en) 1999-09-29 2001-04-05 Prevention of cancer
PCT/DK2002/000231 WO2002080889A2 (en) 2001-04-05 2002-04-05 A combination dosage of a cyclooxygenase (cox) inhibitor, a vitamin d3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer

Publications (1)

Publication Number Publication Date
ATE444072T1 true ATE444072T1 (de) 2009-10-15

Family

ID=25245159

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02759763T ATE444072T1 (de) 2001-04-05 2002-04-05 Prävention von epithelzellkarzinom

Country Status (12)

Country Link
EP (1) EP1389122B1 (de)
AT (1) ATE444072T1 (de)
AU (1) AU2002338311B2 (de)
CA (1) CA2445940C (de)
DE (1) DE60233869D1 (de)
DK (1) DK1389122T3 (de)
ES (1) ES2334215T3 (de)
IS (1) IS6976A (de)
NO (1) NO20034381L (de)
NZ (1) NZ529104A (de)
PT (1) PT1389122E (de)
WO (1) WO2002080889A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20135701L (fi) * 2013-06-26 2014-12-27 Mas Metabolic Analytical Services Oy Farmaseuttisesti käyttökelpoinen ja turvallinen kombinaatio käytettäväksi merkittävien sairauksien hoidossa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
WO2001022974A1 (en) * 1999-09-29 2001-04-05 Colotech A/S Prevention of colorectal cancer

Also Published As

Publication number Publication date
NO20034381D0 (no) 2003-10-01
EP1389122A2 (de) 2004-02-18
CA2445940A1 (en) 2002-10-17
DE60233869D1 (de) 2009-11-12
AU2002338311B2 (en) 2006-08-10
ES2334215T3 (es) 2010-03-08
EP1389122B1 (de) 2009-09-30
IS6976A (is) 2003-10-03
DK1389122T3 (da) 2010-02-01
WO2002080889A3 (en) 2003-02-20
NO20034381L (no) 2003-12-05
CA2445940C (en) 2010-08-24
WO2002080889A2 (en) 2002-10-17
PT1389122E (pt) 2009-12-23
NZ529104A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
AR109263A2 (es) Composición que comprende moxidectina
DK1680128T3 (da) Myo-inositolhexaphosphat til topisk anvendelse
CL2015001086A1 (es) Combinación farmacéutica para el tratamiento y/o quimiosensibilizacion de tumores refractarios a drogas anticancerigenas
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
ATE294585T1 (de) Vorbeugung von kolorektalkrebs
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy
EA200700979A1 (ru) Пероральные твердые лекарственные формы, содержащие низкую дозу эстрадиола
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
BRPI0415232A (pt) uso de xenÈnio com hipotermia para tratar asfixia neonatal
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DE60233869D1 (de) Prävention von epithelzellkarzinom
SE0203817D0 (sv) New composition
IS2392B (is) Sítalópram til að meðhöndla hækkaðan blóðþrýsting
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
GT200400014A (es) Metodo de tratamiento con nelfinavir
BRPI0407174A (pt) Regime de administração para nelfinavir
PL1700597T3 (pl) Kompozycja farmaceutyczna do podawania na skórę, zawierająca łącznie ubidekarenon, despantenol oraz chlorheksydynę lub jej farmakologicznie dopuszczalną sól

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1389122

Country of ref document: EP

REN Ceased due to non-payment of the annual fee